Disclosure Statement Pursuant to the Pink Basic Disclosure Guidelines
ITONIS, INC.
a Nevada corporation
22600-C Lambert Street
Suite 902
Lake Forest, CA 92630
________________________________
(949) 200-8887
www.itonisholdings.com
office@itonisholdings.com
SIC Code 6719
Quarterly Report
For the Period Ending: August 31, 2021
(the "Reporting Period")
Please note that the number of shares outstanding of our Common Stock has remained unchanged since the reporting period ending November 30, 2017: 1,523,409,834
As of the current Reporting Period ending August 31, 2021, the number of shares outstanding of our Common Stock was: 1,523,409,834
As of prior Reporting Period ending May 31, 2021, the number of shares outstanding of our Common Stock was: 1,523,409,834
As of the most recent completed Fiscal Year End date of November 30, 2020, the number of shares outstanding of our Common Stock was: 1,523,409,834
Indicate by check mark whether the company is a shell company (as defined in Rule 405 of the Securities Act of 1933 and
Rule 12b-2 of the Exchange Act of 1934): | Yes: ☐ No: ☒ |
Indicate by check mark whether the company's shell status has changed since the previous reporting period:
Yes: ☐ | No: ☒ |
Indicate by check mark whether a Change in Control1 of the company has occurred over this reporting period:
Yes: ☐ | No: ☒ |
1 "Change in Control" shall mean any events resulting in:
- Any "person" (as such term is used in Sections 13(d) and 14(d) of the Exchange Act) becoming the "beneficial owner" (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly, of securities of the Company representing fifty percent (50%) or more of the total voting power represented by the Company's then outstanding voting securities;
- The consummation of the sale or disposition by the Company of all or substantially all of the Company's assets;
- A change in the composition of the Board occurring within a two (2)-year period, as a result of which fewer than a majority of the directors are directors immediately prior to such change; or
- The consummation of a merger or consolidation of the Company with any other corporation, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity or its parent) at least fifty percent (50%) of the total voting power represented by the voting securities of the Company or such surviving entity or its parent outstanding immediately after such merger or consolidation.
OTC Markets Group Inc. | |
OTC Pink Basic Disclosure Guidelines (v3 February 2021) | Page 1 of 9 |
- Name and address(es) of the issuer and its predecessors (if any)
In answering this item, provide the current name of the issuer any names used by predecessor entities, along with the dates of the name changes.
Itonis, Inc. The company was incorporated as Kenchou, Inc. in Nevada on July 5, 2005. Name changed to Itonis, Inc. on December 2, 2005.
The state of incorporation or registration of the issuer and of each of its predecessors (if any) during the past five years; Please also include the issuer's current standing in its state of incorporation (e.g. active, default, inactive): July 5, 2005 in Nevada. Status is active.
Describe any trading suspension orders issued by the SEC concerning the issuer or its predecessors since inception:
None known.
List any stock split, stock dividend, recapitalization, merger, acquisition, spin-off, or reorganization either currently anticipated or that occurred within the past 12 months: None.
The address(es) of the issuer's principal executive office:
22600-C Lambert Street, Suite 902, Lake Forest, California 92630.
The address(es) of the issuer's principal place of business:
Check box if principal executive office and principal place of business are the same address: ☒
Has the issuer or any of its predecessors been in bankruptcy, receivership, or any similar proceeding in the past five
years? Yes: ☐ | No: ☒ |
If this issuer or any of its predecessors have been the subject of such proceedings, please provide additional details in the space below: N/A.
2) | Security Information | ||
Trading symbol: | ITNS | ||
Exact title and class of securities outstanding: | Common | ||
CUSIP: | 465733103 | ||
Par or stated value: | $0.001 | ||
Total shares authorized: | 1,800,000,000as of date: Aug 31, 2021. | ||
Total shares outstanding: | 1,523,409,834as of date: Aug 31, 2021. | ||
Number of shares in the Public Float2: | 1,087,917,111 | as of date: Aug 31, 2021. | |
Total number of shareholders of record: | 662 | as of date: Aug 31, 2021. |
All additional class(es) of publicly traded securities (if any):
Trading symbol: | No other classes of publicly traded securities. | |
Exact title and class of securities outstanding: | ||
CUSIP: |
2 "Public Float" shall mean the total number of unrestricted shares not held directly or indirectly by an officer, director, any person who is the beneficial owner of more than 10 percent of the total shares outstanding (a "control person"), or any affiliates thereof, or any immediate family members of officers, directors and control persons.
OTC Markets Group Inc. | |
OTC Pink Basic Disclosure Guidelines (v3 February 2021) | Page 2 of 9 |
Par or stated value: | |||||
Total shares authorized: | as of date: | ||||
Total shares outstanding: | as of date: | ||||
Transfer Agent | |||||
Name: | Action Stock Transfer Corp. | ||||
Phone: | (801) 274-1088 | ||||
Email: | action@actionstocktransfer.com | ||||
Address: | 2469 E. Fort Union Blvd, Suite 214, Salt Lake City, Utah | 84121 | |||
Is the Transfer Agent registered under the Exchange Act?3 Yes: ☒ | No: ☐ |
- Issuance History
The goal of this section is to provide disclosure with respect to each event that resulted in any direct changes to the total shares outstanding of any class of the issuer's securities in the past two completed fiscal years and any subsequent interim period.
Disclosure under this item shall include, in chronological order, all offerings and issuances of securities, including debt convertible into equity securities, whether private or public, and all shares, or any other securities or options to acquire such securities, issued for services. Using the tabular format below, please describe these events.
A. Changes to the Number of Outstanding Shares
Check this box to indicate there were no changes to the number of outstanding shares within the past two completed fiscal years and any subsequent periods: ☒
Shares Outstanding as of Second Most | ||||||||||||||||||||||||||||||||
Recent Fiscal Year End: | *Right-click the rows below and select "Insert" to add rows as needed. | |||||||||||||||||||||||||||||||
Opening Balance | ||||||||||||||||||||||||||||||||
Date 11/30/2017 | Common: 1,523,409,834 | |||||||||||||||||||||||||||||||
Preferred: | 500,000 | |||||||||||||||||||||||||||||||
Date of | Transaction | Number of | Class of | Value of | Were the | Individual/ Entity | Reason for share | Restricted | Exempti | |||||||||||||||||||||||
Transaction | type (e.g. new | Shares Issued | Securities | shares | shares issued | Shares were issued | issuance (e.g. for | or | on or | |||||||||||||||||||||||
issuance, | (or cancelled) | issued | at a discount to | to (entities must | cash or debt | Unrestricte | Registrat | |||||||||||||||||||||||||
cancellation, | ($/per | market price at | have individual with | conversion) | - | d as of this | ion Type. | |||||||||||||||||||||||||
shares | share) at | the time of | voting / investment | OR- | Nature | filing. | ||||||||||||||||||||||||||
returned to | Issuance | issuance? | control disclosed). | of Services | ||||||||||||||||||||||||||||
treasury) | (Yes/No) | Provided | ||||||||||||||||||||||||||||||
Shares Outstanding on Date of This Report: | ||||||||||||||||||||||||||||||||
Ending Balance: | ||||||||||||||||||||||||||||||||
Date 8/31/2021 | Common: 1,523,409,834 | |||||||||||||||||||||||||||||||
Preferred: | 500,000 | |||||||||||||||||||||||||||||||
3 To be included in the Pink Current Information tier, the transfer agent must be registered under the Exchange Act.
OTC Markets Group Inc. | |
OTC Pink Basic Disclosure Guidelines (v3 February 2021) | Page 3 of 9 |
Example: A company with a fiscal year end of December 31st, in addressing this item for its quarter ended September 30, 2020, would include any events that resulted in changes to any class of its outstanding shares from the period beginning on January 1, 2018 through September 30, 2020 pursuant to the tabular format above.
Use the space below to provide any additional details, including footnotes to the table above: None
B. Debt Securities, Including Promissory and Convertible Notes
Use the chart and additional space below to list and describe all outstanding promissory notes, convertible notes, convertible debentures, or any other debt instruments that may be converted into a class of the issuer's equity securities.
Check this box if there are no outstanding promissory, convertible notes or debt arrangements: ☐
Date of | Outstanding | Principal | Interest | Maturity | Conversion Terms (e.g. pricing | Name of | Reason for | ||
Note | Balance ($) | Amount at | Accrue | Date | mechanism for determining conversion | Noteholder | Issuance | ||
Issuance | Issuance ($) | d ($) | of instrument to shares) | (entities must have | (e.g. Loan, | ||||
individual with | Services, | ||||||||
voting / investment | etc.) | ||||||||
control disclosed). | |||||||||
11/30/16 | $7,011.99 | $7,011.99 | 5/31/17 | Discount market share price 50%. | Abraham Abu | Loan. | |||
11/30/16 | $16,600 | $16,600 | 5/31/17 | Discount market share price 50%. | CZA, Inc. (control: | Loan | |||
Doris Vo) | |||||||||
2/28/17 | $4,023.98 | $4,023.98 | 8/31/17 | Discount market share price 50%. | Abraham Abu | Loan | |||
2/28/17 | $7,500 | $7,500 | 8/31/17 | Discount market share price 50%. | CZA, Inc. (control: | Loan | |||
Doris Vo) | |||||||||
5/31/17 | $24,000 | $24,000 | 11/30/17 | Discount market share price 50%. | CZA, Inc. (control: | Loan | |||
Doris Vo) | |||||||||
8/31/17 | $18,500 | $18,500 | 2/28/18 | Discount market share price 50%. | CZA, Inc. (control: | Loan | |||
Doris Vo) | |||||||||
2/28/18 | $12,000 | $12,000 | 8/30/18 | Discount market share price 50%. | Charlie Abujudeh | Loan | |||
4/30/18 | $3,760.31 | $3,760.31 | 10/31/18 | Discount market share price 50%. | Charlie Abujudeh | Loan | |||
5/31/18 | $42,000 | $42,000 | 11/30/18 | Discount market share price 50%. | Charlie Abujudeh | Loan | |||
6/30/18 | $5,882 | $5,882 | 12/31/18 | Discount market share price 50%. | Abraham Abu | Loan | |||
8/31/18 | $5,000 | $5,000 | 3/31/19 | Discount market share price 50%. | Charlie Abujudeh | Loan | |||
10/31/18 | $1,800 | $1,800 | 4/30/19 | Discount market share price 50%. | Mark Cheung | Loan | |||
11/30/18 | $13,200 | $13,200 | 5/31/19 | Discount market share price 50%. | Charlie Abujudeh | Loan | |||
2/28/19 | $13,500 | $13,500 | 8/31/19 | Conversion rate of $0.001 per share. | Charlie Abujudeh | Loan | |||
OTC Markets Group Inc. | |||||||||
OTC Pink Basic Disclosure Guidelines (v3 February 2021) | Page 4 of 9 |
5/31/19 | $17,000 | $17,000 | 11/30/19 | Conversion rate of $0.001 per share. | Intermarket | Loan | ||||
Associates | ||||||||||
(control: Charlie | ||||||||||
Abujudeh) | ||||||||||
8/31/19 | $12,000 | $12,000 | 2/29/20 | Conversion rate of $0.001 per share. | Intermarket | Loan | ||||
Associates | ||||||||||
(control: Charlie | ||||||||||
Abujudeh) | ||||||||||
11/30/19 | $10,000 | $10,000 | 5/31/20 | Conversion rate of $0.001 per share. | Intermarket | Loan | ||||
Associates | ||||||||||
(control: Charlie | ||||||||||
Abujudeh) | ||||||||||
2/28/20 | $20,014.90 | $20,014.90 | 8/31/20 | Conversion rate of $0.001 per share. | Intermarket | Loan | ||||
Associates | ||||||||||
(control: Charlie | ||||||||||
Abujudeh) | ||||||||||
8/31/20 | $14,800 | $14,800 | 2/28/21 | Conversion rate of $0.001 per share. | Intermarket | Loan | ||||
Associates | ||||||||||
(control: Charlie | ||||||||||
Abujudeh) | ||||||||||
11/30/20 | $11,500 | $11,500 | 5/30/21 | Conversion rate of $0.001 per share. | Intermarket | Loan | ||||
Associates | ||||||||||
(control: Charlie | ||||||||||
Abujudeh) | ||||||||||
2/28/21 | $9,000. | $9,000. | 8/30/21 | Conversion rate of $0.001 per share. | CZA, Inc. (control: | Loan | ||||
Doris Vo) | ||||||||||
2/28/21 | $3,000. | $3,000. | 8/30/21 | Conversion rate of $0.001 per share. | Intermarket | Loan | ||||
Associates | ||||||||||
(control: Charlie | ||||||||||
Abujudeh) | ||||||||||
5/31/21 | $13,000. | $13,000. | 5/31/22 | Conversion rate of $0.001 per share. | Intermarket | Loan | ||||
Associates | ||||||||||
(control: Charlie | ||||||||||
Abujudeh) | ||||||||||
Use the space below to provide any additional details, including footnotes to the table above: None
- Financial Statements
A. The following financial statements were prepared in accordance with:
- U.S. GAAP ☐ IFRS
OTC Markets Group Inc. | |
OTC Pink Basic Disclosure Guidelines (v3 February 2021) | Page 5 of 9 |
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
ITonis Inc. published this content on 08 December 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 08 December 2021 20:51:09 UTC.